Omeros corporation announces approval of icd-10 codes for hsct-tma diagnosis and for narsoplimab administration

Seattle--(business wire)--omeros corporation (nasdaq: omer) today announced that the centers for disease control and prevention (cdc) has approved an international classification of diseases (icd-10) diagnosis code, m31.11 – hematopoietic stem cell transplantation-associated thrombotic microangiopathy (hsct-tma). the absence of a specific hsct-tma diagnosis code has led to underreporting of diagnoses and inaccurate coding, which has complicated reporting of the incidence and outcomes of the dis
OMER Ratings Summary
OMER Quant Ranking